# Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

> **NCT01452373** · PHASE3 · COMPLETED · sponsor: **EndoCeutics Inc.** · enrollment: 238 (actual)

## Conditions studied

- Vasomotor Symptoms
- Hot Flushes

## Interventions

- **DRUG:** Placebo
- **DRUG:** DHEA and Acolbifene

## Key facts

- **NCT ID:** NCT01452373
- **Lead sponsor:** EndoCeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-12
- **Final completion:** 2013-05
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452373, "Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01452373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*